These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 35240956)

  • 21. Berberine a traditional Chinese drug repurposing: Its actions in inflammation-associated ulcerative colitis and cancer therapy.
    Zhu C; Li K; Peng XX; Yao TJ; Wang ZY; Hu P; Cai D; Liu HY
    Front Immunol; 2022; 13():1083788. PubMed ID: 36561763
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The therapeutic potential of Berberine chloride hydrate against harmaline-induced motor impairments in a rat model of tremor.
    Vaziri Z; Abbassian H; Sheibani V; Haghani M; Nazeri M; Aghaei I; Shabani M
    Neurosci Lett; 2015 Mar; 590():84-90. PubMed ID: 25643620
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatoprotective effects of berberine on acetaminophen-induced hepatotoxicity in mice.
    Zhao Z; Wei Q; Hua W; Liu Y; Liu X; Zhu Y
    Biomed Pharmacother; 2018 Jul; 103():1319-1326. PubMed ID: 29864914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Efficacies of Berberine against Neurological Disorders: An Update of Pharmacological Effects and Mechanisms.
    Shou JW; Shaw PC
    Cells; 2022 Feb; 11(5):. PubMed ID: 35269418
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Berberine ameliorates β-amyloid pathology, gliosis, and cognitive impairment in an Alzheimer's disease transgenic mouse model.
    Durairajan SS; Liu LF; Lu JH; Chen LL; Yuan Q; Chung SK; Huang L; Li XS; Huang JD; Li M
    Neurobiol Aging; 2012 Dec; 33(12):2903-19. PubMed ID: 22459600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Berberine Ameliorates Cognitive Disorder via GSK3β/PGC-1α Signaling in APP/PS1 Mice.
    Yang M; Wang J
    J Nutr Sci Vitaminol (Tokyo); 2022; 68(3):228-235. PubMed ID: 35768254
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Berberine ameliorates methotrexate-induced liver injury by activating Nrf2/HO-1 pathway and PPARγ, and suppressing oxidative stress and apoptosis in rats.
    Mahmoud AM; Hozayen WG; Ramadan SM
    Biomed Pharmacother; 2017 Oct; 94():280-291. PubMed ID: 28763751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sodium valproate enhances doxorubicin-induced cognitive dysfunction in Wistar rats.
    Verma T; Mallik SB; Ramalingayya GV; Nayak PG; Kishore A; Pai KSR; Nandakumar K
    Biomed Pharmacother; 2017 Dec; 96():736-741. PubMed ID: 29049976
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Berberine protects Kawasaki disease-induced human coronary artery endothelial cells dysfunction by inhibiting of oxidative and endoplasmic reticulum stress.
    Xu M; Qi Q; Men L; Wang S; Li M; Xiao M; Chen X; Wang S; Wang G; Jia H; Liu C
    Vascul Pharmacol; 2020 Apr; 127():106660. PubMed ID: 32070767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protective effect of berberine, an isoquinoline alkaloid ameliorates ethanol-induced oxidative stress and memory dysfunction in rats.
    Patil S; Tawari S; Mundhada D; Nadeem S
    Pharmacol Biochem Behav; 2015 Sep; 136():13-20. PubMed ID: 26159088
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Berberine Alleviates Amyloid-Beta Pathology in the Brain of APP/PS1 Transgenic Mice via Inhibiting β/γ-Secretases Activity and Enhancing α-Secretases.
    Cai Z; Wang C; He W; Chen Y
    Curr Alzheimer Res; 2018; 15(11):1045-1052. PubMed ID: 29962345
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Berberine Metabolites Stimulate GLP-1 Secretion by Alleviating Oxidative Stress and Mitochondrial Dysfunction.
    Yang WL; Zhang CY; Ji WY; Zhao LL; Yang FY; Zhang L; Cao X
    Am J Chin Med; 2024; 52(1):253-274. PubMed ID: 38351702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Berberine improves cognitive impairment by promoting autophagic clearance and inhibiting production of β-amyloid in APP/tau/PS1 mouse model of Alzheimer's disease.
    Huang M; Jiang X; Liang Y; Liu Q; Chen S; Guo Y
    Exp Gerontol; 2017 May; 91():25-33. PubMed ID: 28223223
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ameliorating Ribosylation-Induced Amyloid-β Pathology by Berberine via Inhibiting mTOR/p70S6K Signaling.
    Wang YY; Yan Q; Huang ZT; Zou Q; Li J; Yuan MH; Wu LQ; Cai ZY
    J Alzheimers Dis; 2021; 79(2):833-844. PubMed ID: 33361598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Overview on Chemotherapy-induced Cognitive Impairment and Potential Role of Antidepressants.
    Das A; Ranadive N; Kinra M; Nampoothiri M; Arora D; Mudgal J
    Curr Neuropharmacol; 2020; 18(9):838-851. PubMed ID: 32091339
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Berberine: A Plant-derived Alkaloid with Therapeutic Potential to Combat Alzheimer's disease.
    Singh AK; Singh SK; Nandi MK; Mishra G; Maurya A; Rai A; Rai GK; Awasthi R; Sharma B; Kulkarni GT
    Cent Nerv Syst Agents Med Chem; 2019; 19(3):154-170. PubMed ID: 31429696
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Functional effects of berberine in modulating mitochondrial dysfunction and inflammatory response in the respective amyloidogenic cells and activated microglial cells - In vitro models simulating Alzheimer's disease pathology.
    Wong LR; Tan EA; Lim MEJ; Shen W; Lian XL; Wang Y; Chen L; Ho PC
    Life Sci; 2021 Oct; 282():119824. PubMed ID: 34265361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Berberine ameliorates intrahippocampal kainate-induced status epilepticus and consequent epileptogenic process in the rat: Underlying mechanisms.
    Sedaghat R; Taab Y; Kiasalari Z; Afshin-Majd S; Baluchnejadmojarad T; Roghani M
    Biomed Pharmacother; 2017 Mar; 87():200-208. PubMed ID: 28061403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oxyberberine, an absorbed metabolite of berberine, possess superior hypoglycemic effect via regulating the PI3K/Akt and Nrf2 signaling pathways.
    Dou Y; Huang R; Li Q; Liu Y; Li Y; Chen H; Ai G; Xie J; Zeng H; Chen J; Luo C; Su Z
    Biomed Pharmacother; 2021 May; 137():111312. PubMed ID: 33524788
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dietary agents in mitigating chemotherapy-related cognitive impairment (chemobrain or chemofog): first review addressing the benefits, gaps, challenges and ways forward.
    Raghu SV; Kudva AK; Rao S; Prasad K; Mudgal J; Baliga MS
    Food Funct; 2021 Nov; 12(22):11132-11153. PubMed ID: 34704580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.